By Julie Steenhuysen CHICAGO (Reuters) - Berg, a private company that uses artificial intelligence to discover new drugs and diagnostics, will help England's national genomics project mine DNA and health data from thousands of British citizens for potential drug targets. Berg, based in Boston, was co-founded in 2006 by Silicon Valley real estate billionaire Carl Berg. Its newest agreement is with the Genomics England 100,000 Genomes Project, which aims to accelerate development of new diagnostics and treatments through a year-long industry trial, company executives told Reuters.
from Science News Headlines - Yahoo News http://ift.tt/1LO5Duh
via RO Water Filter